Cholangitis primary prevention: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(4 intermediate revisions by one other user not shown)
Line 9: Line 9:
* There are no established measures for the primary prevention of cholangitis in otherwise healthy people.  
* There are no established measures for the primary prevention of cholangitis in otherwise healthy people.  
* Treatment of [[gallstones]], [[tumors]], and infestations of parasites may reduce the risk for some people.
* Treatment of [[gallstones]], [[tumors]], and infestations of parasites may reduce the risk for some people.
* Patients undergoing [[ERCP]] should have prophylactic antibiotics.
* Patients undergoing [[ERCP]] should have prophylactic antibiotics.<ref name="pmid1406012">{{cite journal| author=Sauter G, Ruckdeschel G, Sauerbruch T| title=[Antibiotic prevention and therapy of infectious complications in ERCP]. | journal=Leber Magen Darm | year= 1992 | volume= 22 | issue= 5 | pages= 173-6 | pmid=1406012 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1406012  }} </ref>


*Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages<ref name="urlAscending cholangitis Prevention - Epocrates Online">{{cite web |url=https://online.epocrates.com/diseases/34544/Ascending-cholangitis/Prevention |title=Ascending cholangitis Prevention - Epocrates Online |format= |work= |accessdate=}}</ref>
*Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages<ref name="urlAscending cholangitis Prevention - Epocrates Online">{{cite web |url=https://online.epocrates.com/diseases/34544/Ascending-cholangitis/Prevention |title=Ascending cholangitis Prevention - Epocrates Online |format= |work= |accessdate=}}</ref><ref name="pmid7986900">{{cite journal| author=van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ| title=Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. | journal=Clin Infect Dis | year= 1994 | volume= 19 | issue= 2 | pages= 279-86 | pmid=7986900 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7986900  }} </ref><ref name="pmid10695743">{{cite journal| author=Lillemoe KD| title=Surgical treatment of biliary tract infections. | journal=Am Surg | year= 2000 | volume= 66 | issue= 2 | pages= 138-44 | pmid=10695743 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10695743  }} </ref><ref name="pmid7716962">{{cite journal| author=Cybulski Z, Solarski J, Majewski W| title=[Infection as a risk factor in biliary system surgery]. | journal=Wiad Lek | year= 1994 | volume= 47 | issue= 15-16 | pages= 619-24 | pmid=7716962 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7716962  }} </ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:FinalQCRequired]]
[[Category:FinalQCRequired]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Primary care]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Gastroenterology]]
[[Category:Surgery]]
[[Category:Surgery]]

Latest revision as of 20:55, 29 July 2020

Cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangitis primary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangitis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangitis primary prevention

CDC on Cholangitis primary prevention

Cholangitis primary prevention in the news

Blogs on Cholangitis primary prevention

Directions to Hospitals Treating Cholangitis

Risk calculators and risk factors for Cholangitis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Farwa Haideri [3]

Overview

There are no established measures for the primary prevention of cholangitis in otherwise healthy people, Giving antibiotics in people undergoing biliary procedures like endoscopic retrograde cholangiopancreatography (ERCP) may benefit from antibiotics.

Primary Prevention

  • There are no established measures for the primary prevention of cholangitis in otherwise healthy people.
  • Treatment of gallstones, tumors, and infestations of parasites may reduce the risk for some people.
  • Patients undergoing ERCP should have prophylactic antibiotics.[1]
  • Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages[2][3][4][5]

References

  1. Sauter G, Ruckdeschel G, Sauerbruch T (1992). "[Antibiotic prevention and therapy of infectious complications in ERCP]". Leber Magen Darm. 22 (5): 173–6. PMID 1406012.
  2. "Ascending cholangitis Prevention - Epocrates Online".
  3. van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ (1994). "Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis". Clin Infect Dis. 19 (2): 279–86. PMID 7986900.
  4. Lillemoe KD (2000). "Surgical treatment of biliary tract infections". Am Surg. 66 (2): 138–44. PMID 10695743.
  5. Cybulski Z, Solarski J, Majewski W (1994). "[Infection as a risk factor in biliary system surgery]". Wiad Lek. 47 (15–16): 619–24. PMID 7716962.


Template:WikiDoc Sources